Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
294 items
National Eye Institute logo.

Gene Transfer for Leber Congenital Amaurosis

Two groups of investigators have reported independently on their initial observations from Phase I clinical trials of gene transfer for Leber congenital amaurosis (LCA) caused by mutations in the RPE65 gene.
National Eye Institute logo.

Older Corneas Suitable for Transplantation

The age pool of corneas for transplant should be expanded to include donors up to 75 years of age, based on findings from a study funded by the National Eye Institute (NEI), one of the National Institutes of Health.
National Eye Institute logo.

Survey Shows Americans Lack Critical Facts about Maintaining Eye Health

Most Americans do not know the risks and warning signs of diseases that could blind them if they don’t seek timely detection and treatment.
Two young boys smile at camera. A dark spot representing vision loss from AMD blocks the center of the image.

Comparison of AMD Treatments Trials (CATT): Lucentis - Avastin Trial

The National Eye Institute (NEI) of the National Institutes of Health (NIH) announces the start of a multicenter clinical trial to compare the relative safety and effectiveness of two drugs currently used to treat advanced age-related macular degeneration
National Eye Institute logo.

Statement on Clinical Trial of Gene Transfer Therapy for Childhood-Onset Blindness

The National Eye Institute (NEI) of the National Institutes of Health (NIH) is supporting a phase I clinical trial to assess the safety of gene transfer in treating people with a form of Leber congenital amaurosis (LCA).
Two boys smile at camera. Dark spot in center of image represents vision loss from AMD.

Laser Treatment Does Not Prevent Vision Loss for People with Early Age-Related Macular Degeneration

An extensive NIH-supported study has found that low-intensity laser treatment, thought to be possibly beneficial in slowing or preventing the loss of vision from AMD.
National Eye Institute logo.

Nuevo estudio clínico a nivel nacional evaluarí el efecto de los antioxidantes y el aceite de pescado para prevenir el avance de la degeneracin macular relacionada con la edad

Aproximadamente 100 centros clínicos están buscando 4.000 personas entre las edades de 50 a 85 años
National Eye Institute logo.

New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)

Nearly 100 Clinical Centers Are Now Seeking 4,000 Study Participants Ages 50-85 Who Have AMD
National Eye Institute logo.

Study Finds Most Americans Have Good Vision, But 14 Million Are Visually Impaired

A National Institutes of Health (NIH) study has found that although 94 percent of Americans aged 12 and older have good vision, the remaining six percent, or 14 million, are visually impaired. Of these, more than 11 million have uncorrected visual..
National Eye Institute logo.

Agreement Signed to Expand Vision Research Collaborations between the United States and India

The National Institutes of Health (NIH) today announced the signing of a United States-India Statement of Intent for collaboration on expansion of vision research.

Want more news from NEI?

Connect with us through social media to stay up to date on vision research, eye health, and other topics!

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248